Skip to main content
Bio-Techne10-Q: CEO change

Bio-Techne confirms new CEO transition with associated non-recurring costs

What happened

The company is undergoing a CEO transition with Kim Kelderman now President and CEO, and is incurring costs related to the change.

Source

SEC EDGARFeb 4, 2026

Quarterly report (Form 10-Q)

Bio-Techne 10-Q

Filing excerpt

The Company’s non-GAAP adjusted operating margin and adjusted net earnings, in total and on a per share basis, also excludes acquisition related expenses... and other non-recurring items including certain costs related to the transition to a new CEO...

sec.gov/Archives/edgar/data/842023/000110465926010335/tech-20251231x1...Read the full source

Other signals in this filing (7)

Extracted by Autobound

From the Signal API record
Signal
10-Q: CEO change

What this signalsA new leader often reviews the tools the team uses.

Filed
Feb 4, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Details

CIK
842023
Accession number
0001104659-26-010335
Timeframe
Current quarter
Filing year
2026
Fiscal year
0
Why it matters
Full vendor review - highest priority
Signal category
Leadership

Extraction

Confidence
High
Relevance
95%
Sentiment
Neutral
Detected
Feb 10, 2026
signal_type
sec-10q
signal_subtype
ceoChange

Use this data

Get every 10-Q signal for Bio-Techne and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bio-Techne this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/616db4a5-eb30-4129-b2f3-3ae1f7aabbec returns this record as JSON. POST /v1/companies/enrich returns every signal for bio-techne.com.

{
  "signal_id": "616db4a5-eb30-4129-b2f3-3ae1f7aabbec",
  "signal_type": "sec-10q",
  "signal_subtype": "ceoChange",
  "detected_at": "2026-02-10T08:25:18.163+00:00",
  "company": {
    "name": "Bio-Techne",
    "domain": "bio-techne.com"
  },
  "data": {
    "detail": "The company is undergoing a CEO transition with Kim Kelderman now President and CEO, and is incurring costs related to the change. A new CEO often triggers strategic reviews, budget re-allocations, and new initiatives within 90-180 days, creating significant opportunities for new vendors.",
    "metrics": {
      "timeframe": "current_quarter"
    },
    "summary": "Bio-Techne confirms new CEO transition with associated non-recurring costs",
    "excerpts": "The Company’s non-GAAP adjusted operating margin and adjusted net earnings, in total and on a per share basis, also excludes acquisition related expenses... and other non-recurring items including certain costs related to the transition to a new CEO...",
    "relevance": 0.95,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/842023/000110465926010335/tech-20251231x10q.htm",
    "filing_date": "2026-02-04",
    "filing_year": 2026,
    "fiscal_year": 0,
    "sales_relevance": "Full vendor review - highest priority",
    "signal_category": "leadership"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.